Biogen Inc (BIIB) Biogen to Report Second Quarter 2022 Financial Results July 20, 2022
Biogen Inc (NASDAQ: BIIB) Q2 2022 Earnings Conference
Biogen Inc. (BIIB) Q2 2022 Earnings Call Transcript
Biogen Inc. (NASDAQ: BIIB) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Michael Hencke — Head of Investor Relations. Michel Vounatsos — Chief Executive Officer Priya Singhal — Interim…
AlphaGraphs
Infographic: Key highlights from Biogen (BIIB) Q2 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today. Total revenue decreased 7% year-over-year to $2.58 billion. Net income attributable to Biogen Inc.…
Market News
Biogen’s (BIIB) long-term prospects look intact despite Alzheimer’s drug setback
Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition and the ambitious launch of…
AlphaGraphs
Key highlights from Biogen’s (BIIB) Q1 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported first quarter 2022 earnings results today. Total revenue decreased 6% year-over-year to $2.53 billion. GAAP net income attributable to Biogen Inc.…
Biogen Inc (BIIB) Biogen Fourth Quarter and Full Year 2021 Earnings Call
Biogen Inc (NASDAQ: BIIB) Q4 2021 Earnings Conference
Biogen, Inc. (BIIB) Q4 2021 Earnings Call Transcript
Biogen, Inc. (NASDAQ: BIIB) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Michael Hencke — Head of Investor Relations Michel Vounatsos — Chief Executive Officer Priya Singhal — Head…
Market News
Biogen (BIIB) stock research summary | Q3 2021
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB)…
Biogen Inc (BIIB) Q3 2021 Earnings Call
Biogen Inc (NASDAQ: BIIB) Q3 2021 Earnings Conference
Biogen, Inc. (BIIB) Q3 2021 Earnings Call Transcript
Biogen, Inc. (NASDAQ: BIIB) Q3 2021 earnings call dated Oct. 20, 2021 Corporate Participants: Michael Hencke — Investor Relations Michel Vounatsos — Chief Executive Officer Alfred Sandrock — Head of Research…